XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
AVD Total
Balance at Dec. 31, 2019   $ 3,324 $ 90,572 $ (5,698) $ 274,118 $ (18,160) $ 344,156
Balance (in shares) at Dec. 31, 2019   33,233,614       3,061,040  
Common stock issued under ESPP   $ 2 350       352
Common stock issued under ESPP, (in Shares)   22,776          
Cash dividends on common stock ($0.02 per share)         (586)   (586)
Foreign currency translation adjustment, net       (9,063)     (9,063)
Stock-based compensation     1,357       1,357
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes)   $ (7) (2,522)       (2,529)
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares   (67,969)          
Net income         520   520
Balance at Mar. 31, 2020   $ 3,319 89,757 (14,761) 274,052 $ (18,160) 334,207
Balance (in shares) at Mar. 31, 2020   33,188,421       3,061,040  
Balance at Dec. 31, 2019   $ 3,324 90,572 (5,698) 274,118 $ (18,160) 344,156
Balance (in shares) at Dec. 31, 2019   33,233,614       3,061,040  
Foreign currency translation adjustment, net $ (8,822)            
Net income 7,334            
Balance at Sep. 30, 2020   $ 3,335 93,273 (14,520) 280,866 $ (18,160) 344,794
Balance (in shares) at Sep. 30, 2020   33,337,075       3,061,040  
Balance at Mar. 31, 2020   $ 3,319 89,757 (14,761) 274,052 $ (18,160) 334,207
Balance (in shares) at Mar. 31, 2020   33,188,421       3,061,040  
Foreign currency translation adjustment, net       324     324
Stock-based compensation     1,188       1,188
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes)   $ 5 49       54
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares   40,657          
Net income         3,887   3,887
Balance at Jun. 30, 2020   $ 3,324 90,994 (14,437) 277,939 $ (18,160) 339,660
Balance (in shares) at Jun. 30, 2020   33,229,078       3,061,040  
Common stock issued under ESPP   $ 3 366       369
Common stock issued under ESPP, (in Shares)   26,892          
Foreign currency translation adjustment, net (83)     (83)     (83)
Stock-based compensation     1,231       1,231
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes)   $ 8 682       690
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares   81,105          
Net income 2,927       2,927   2,927
Balance at Sep. 30, 2020   $ 3,335 93,273 (14,520) 280,866 $ (18,160) $ 344,794
Balance (in shares) at Sep. 30, 2020   33,337,075       3,061,040  
Balance at Dec. 31, 2020 $ 360,736 $ 3,394 96,642 (9,322) 288,182 $ (18,160)  
Balance (in shares) at Dec. 31, 2020 33,922,433 33,922,433       3,061,040  
Common stock issued under ESPP $ 340 $ 2 338        
Common stock issued under ESPP, (in Shares)   25,120          
Cash dividends on common stock ($0.02 per share) (596)       (596)    
Foreign currency translation adjustment, net (2,503)     (2,503)      
Stock-based compensation 1,792   1,792        
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes) (2,794) $ (7) (2,787)        
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares   (73,231)          
Net income 3,071       3,071    
Balance at Mar. 31, 2021 360,046 $ 3,389 95,985 (11,825) 290,657 $ (18,160)  
Balance (in shares) at Mar. 31, 2021   33,874,322       3,061,040  
Balance at Dec. 31, 2020 $ 360,736 $ 3,394 96,642 (9,322) 288,182 $ (18,160)  
Balance (in shares) at Dec. 31, 2020 33,922,433 33,922,433       3,061,040  
Foreign currency translation adjustment, net $ (3,048)            
Net income 13,713            
Balance at Sep. 30, 2021 $ 368,341 $ 3,428 99,917 (12,370) 300,105 $ (22,739)  
Balance (in shares) at Sep. 30, 2021 34,272,665 34,272,665       3,361,040  
Balance at Mar. 31, 2021 $ 360,046 $ 3,389 95,985 (11,825) 290,657 $ (18,160)  
Balance (in shares) at Mar. 31, 2021   33,874,322       3,061,040  
Cash dividends on common stock ($0.02 per share) (600)       (600)    
Foreign currency translation adjustment, net 2,914     2,914      
Stock-based compensation 1,806   1,806        
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes) 61 $ 39 22        
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares   387,329          
Net income 5,144       5,144    
Balance at Jun. 30, 2021 369,371 $ 3,428 97,813 (8,911) 295,201 $ (18,160)  
Balance (in shares) at Jun. 30, 2021   34,261,651       3,061,040  
Common stock issued under ESPP 403 $ 2 401        
Common stock issued under ESPP, (in Shares)   25,662          
Cash dividends on common stock ($0.02 per share) (594)       (594)    
Foreign currency translation adjustment, net (3,459)     (3,459)      
Stock-based compensation 1,711   1,711        
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes) (10) $ (2) (8)        
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares   (14,648)          
Shares repurchased (4,579)         $ (4,579)  
Shares repurchased (In Shares)           300,000  
Net income 5,498       5,498    
Balance at Sep. 30, 2021 $ 368,341 $ 3,428 $ 99,917 $ (12,370) $ 300,105 $ (22,739)  
Balance (in shares) at Sep. 30, 2021 34,272,665 34,272,665       3,361,040